Compositions and methods relating to lung specific genes
First Claim
Patent Images
1. A LSG comprising:
- (a) a polynucleotide of SEQ ID NO;
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, or 74, or a variant thereof;
(b) a polypeptide expressed by a polynucleotide of SEQ ID NO;
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, or 74, or a variant thereof;
or (c) a polynucleotide which is capable of hybridizing under stringent conditions to the antisense sequence of SEQ ID NO;
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or 74.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention relates to LSG polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.
-
Citations
16 Claims
-
1. A LSG comprising:
-
(a) a polynucleotide of SEQ ID NO;
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, or 74, or a variant thereof;
(b) a polypeptide expressed by a polynucleotide of SEQ ID NO;
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, or 74, or a variant thereof;
or(c) a polynucleotide which is capable of hybridizing under stringent conditions to the antisense sequence of SEQ ID NO;
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or 74. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)
-
Specification